Roswell Park Hosts Prestigious National Conference The Future Of Cancer Research: Science And Patient Impact

Main Category: Cancer / Oncology
Also Included In: Conferences
Article Date: 10 Oct 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Roswell Park Cancer Institute (RPCI) will bring together national cancer experts from around the United States to discuss "The Future of Cancer Research: Science and Patient Impact" during a Centennial Symposium sponsored by the American Association for Cancer Research (AACR), October 27-28, Research Studies Center, RPCI.

This forward-looking Centennial Symposium also will honor the long history that the Roswell Park Cancer Institute has had with AACR. RPCI scientists, among the founders of AACR, recognized the need to understand the causes of cancer and in 1907 made a commitment to meet those challenges through an organized national effort.

"Roswell Park is privileged to host the AACR Centennial Symposium honoring the contributions of individuals and organizations which have contributed to a century of progress in cancer research," said Donald L. Trump, MD, FACP, President & CEO, RPCI. "This event offers a significant opportunity for a distinguished roster of national leaders in cancer to gather and share their insights into future opportunities for advances in cancer prevention, research, education and treatment."

Keynote Presentations

Monday, October 27, Noon - "Transforming FDA Science: Implications for Cancer Research," - Frank M. Torti, MD, MPH, U.S. Food and Drug Administration, Rockville, MD

Monday, October 27, 7 pm - "Future Trends in Cancer Research" - Donald S. Coffey, PhD, Johns Hopkins University School of Medicine, Baltimore, MD

Tuesday, October 28, 12:15 pm - "The Future of Cancer Research" - Harold L. Moses, MD, Vanderbilt-Ingram Cancer Center, Nashville, TN.

Plenary Sessions

"Experimental and Molecular Therapeutic Advances - What the Future Holds"
Chairperson: Candace S. Johnson, PhD, RPCI

"The Emerging Fields of Proteomics and Systems Biology"
Chairperson: Kenneth H. Buetow, PhD, National Cancer Institute, Bethesda, MD

"The Knowledge Within Genomics and Cancer Genomics Research"
Chairperson: Nickolas Papadopoulos, PhD, Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins Institutes' Ludwig Center for Cancer Genetics and Therapeutics, Baltimore, MD

"The Relevance and Challenges of Cancer Prevention Research with a Focus on Molecular Epidemiology"
Chairperson: Christine B. Ambrosone, PhD, RPCI

Educational Sessions

"Impact of Translational Research on the Clinic - Molecular Targeted Therapy and Patient Outcome"

Chairperson: Clara D. Bloomfield, MD, The Ohio State University Comprehensive Cancer Center, Columbus, OH

"Application of Innovative Technologies of the 21st Century - An Overview"
Chairperson: Norma J. Nowak, PhD, RPCI

This symposium is a Continuing Medical Education (CME) activity. AMA PRA Category 1 Credits™ will be available.

Roswell Park Cancer Institute, founded in 1898, is the nation's first cancer research, treatment and education center. The Institute was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. RPCI is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation's leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs.

Roswell Park Cancer Institute